In this report, we describe the involvement of the quail neuroretina 1 (QN1) protein in retinal development. The Qn1 cDNA was isolated as a gene speci®cally expressed at the onset of neuronal cell cycle withdrawal (Bidou et al., Mech. Dev. 43 (1993) 159). Qn1 is located in the cytoplasm in proliferating cells during the early stages of the development. Its distribution changes, becoming predominantly nuclear, in neurons during establishment of the quiescent state upon the differentiation. We decreased the amount of QN1 protein by an antisense strategy in vitro or in vivo. This decrease of the amount of QN1 protein results in additional mitosis and in severe abnormalities such as retinal dysplasia. Our results suggest that QN1 plays a key role at the onset of neuronal cell cycle withdrawal. q
Introduction
The generation of neurons in the developing retina is a complex process in which differentiation is closely linked to terminal mitosis. Genes that negatively regulate proliferation in the cell are of great interest because they are involved in processes such as development and tumour formation. Many molecules involved in cell cycle regulation and arrest have been studied.
An intricate network of intra-and extracellular signalling pathways that act on the basic cellular machinery govern cell proliferation. Cyclin-dependent kinases (CDK) form the core of this machinery. The activity of CDKs depends on an association with cyclin and phosphorylation. Retinoblastoma protein (pRb), a critical regulator of G1/S and G1/G0 transition, is one of the main substrates of CDKs. Entry into the S phase is negatively regulated by inhibitors of CDKs, known as CDKIs. These inhibitors may be assigned to two classes: the Ink4 class (containing p15, p16, p18, and p19), and the Cip/Kip class (containing p21, p27, and p57) (Sherr and Roberts, 1995) . The members of the Ink4 family speci®cally inhibit CDK4 and CDK6, whereas the members of the Cip/ Kip family inhibit all CDKs involved in G1/S transition.
pRb plays key roles in the regulation of the G1/S transition, withdrawal from the cell cycle and initiation of terminal differentiation. pRb acts as a transcriptional repressor if hypophosphorylated, by sequestrating transcription factors of the E2F family for the promoters of some genes and for some promoters, by recruiting histone deacetylase (Luo et al., 1998) . However, pRb may also promote differentiation independently of its ability to abolish the expression of E2F target genes. pRb seems to act as a co-activator of transcriptional factors involved in differentiation, such as Myo D in skeletal muscle and c-Jun in keratinocytes (Zhang, 1999) . Genes have been isolated that negatively regulate the cell cycle and promote differentiation, but do not form part of the core of the cell cycle machinery: the gadd, gas and gax genes, and genes encoding prohibitin and statin. It has recently been shown that prohibitin , a potential tumour suppressor protein, binds to the pRb and represses E2F transcriptional activity. Prohibitin has been described as a novel regulator of E2F function, channelling speci®c signalling cascades to the cell cycle regulation machinery.
GADD45 (growth arrest and DNA damage-inducible gene) is a p53-responsive gene encoding a protein that interacts with p21CIP1 and proliferating cell nuclear antigen (Kastan et al., 1992; Kearsey et al., 1995; Smith et al., 1994) . GADD45 and p21CIP1 are upregulated by wildtype p53, and these proteins may be responsible for the repression of growth by this tumour suppressor (Carrier et al., 1994; Kastan et al., 1992; Landesman et al., 1997; Zhan et al., 1994a) . GADD153 encodes a C/EBP homologous protein that binds to C/EBP isoforms, the resulting heterodimers binding novel DNA recognition sites (Barone et al., 1994; Ubeda et al., 1996) . Exogenous expression of GADD45 or GADD153 may have antiproliferative effects (Barone et al., 1994; Chen et al., 1996; Matsumoto et al., 1996; Zhan et al., 1994b) . The expression of GADD genes is induced by medium depletion and by genotoxic agents that cause DNA damage (Delmastro et al., 1997; Jackman et al., 1994; Jeong et al., 1996; Luethy and Holbrook, 1992) .
The growth arrest-speci®c gas genes are expressed preferentially in cultured cells entering a quiescent state following serum deprivation or growth to con¯uence (Lih et al., 1996; Schneider et al., 1988) . In vivo, gas genes expression has been observed during the growth arrest that accompanies the terminal differentiation of cells during the development of peripheral nerves (Adlkofer et al., 1995; Magyar et al., 1996) . Individual gas genes have been implicated in a variety of biological functions, including the control of micro®la-ment organization , nerve cell growth and differentiation, apoptosis (Fabbretti et al., 1995) , tyrosine kinase receptor activity , and the negative (Del Sal et al., 1994) and positive Lih et al., 1996) control of cell cycling.
Like gas genes, the gax gene, encoding a homeoprotein, is expressed during development when vascular smooth muscle cells (VSMC) or rodent ®broblasts withdraw from the cell cycle. The gax mRNA is downregulated if the ®bro-blasts or VSMC are stimulated by mitogens (Fisher et al., 1997; Gorski et al., 1993) . The overexpression of gax results in G0/G1 cell cycle arrest in rodent VSMC and ®broblasts. This effect is mediated by the CDK inhibitor p21CIP1 (Smith et al., 1997) and the overexpression of gax in vivo, early in the development of the heart of chicken embryos, inhibits cardiomyocyte proliferation and perturbs the morphogenesis of this organ (Fisher et al., 1997) .
Statin (Sandig et al., 1994 ) is a 57 kDa protein expressed exclusively in the nuclei of non-proliferating mammalian cells. Recent studies have suggested that statin may be involved in the maintenance of growth arrest. Statin, a nuclear protein previously reported to be produced by cells in G0, is lost from quiescent ®broblasts in culture if they are induced to enter the cell cycle by the addition of growth factors, or the removal of contact inhibition. This protein is associated with the nuclear membrane in cell growth arrest. The properties of statin closely resemble those of nuclear lamins, members of the intermediate ®lament family.
The retina is derived from the optic vesicle by waves of proliferation, differentiation and apoptosis, leading to a well-de®ned structure of concentric layers. The regulation of withdrawal from the cell cycle is a critical factor in the histogenesis of the retina. It has been shown that histogenesis of the photoreceptors and Mu Èller cells is perturbed in p27 Kip1-de®cient mice (Levine et al., 2000; Nakayama et al., 1996) . Thus, the balance between proliferation and differentiation must be tightly regulated. Either the molecular machinery of the cell cycle regulates initiation of the differentiation program or these molecules are directly involved in the determination of cell fate. p27 seems to be involved in withdrawal from the cell cycle, but less so in the differentiation of glial cells (Levine et al., 2000; Ohnuma et al., 1999) . The pRb protein is a key molecule in the arrest of the cell cycle and the switch to differentiation. In retina development, the conversion of pRb from its hyperphosphorylated to its hypophosphorylated form and a decrease in the total amount of pRb are observed when most of the cells stop dividing and begin to differentiate. The pRbrelated protein, p107, is also progressively downregulated and p130 levels increase. Moreover, when neuroretina cells stop dividing and become quiescent, the E2F-1/RB complex is followed by the appearance of the E2F-4/p130 complex, suggesting that cell cycle exit and re-entry may depend on Rb/E2F-1 interaction. The rate of pRb synthesis decreases in post-mitotic cells, as shown by in vivo metabolic labelling of the pRb protein, but the level of the Rb transcript remains constant (Kastner et al., 1998) .
Here we report the characterization of a speci®c gene involved in the control of de®nitive neuronal quiescence. To isolate speci®c genes for the quiescent state, we constructed a subtracted cDNA library (Bidou et al., 1993) . Differential screening of this library led to the isolation of QN1 (quail neuroretina 1). We have previously shown that in quail neuroretina (in vivo) the proportion of QN1-expressing cells is inversely proportional to the number of BrdUlabelled cells. Furthermore, experiments with QN1 antisense oligonucleotides and retinal neuronal cell clones showed that the level of DNA synthesis was higher and there were 35% more BrdU-labelled nuclei in cultures treated with the antisense oligonucleotide than in cultures treated with the sense oligonucleotide. These results clearly show that QN1 is involved in cell growth arrest.
The Qn1 cDNA encodes a protein that contains no domain or motif corresponding to a known protein but which has a sequence similar to that of the KIAA 1009 cDNA (Nagase et al., 1999) . The function of the protein corresponding to this cDNA is unknown. In this study, we demonstrate the expression of the gene and show major changes in the subcellular distribution of the QN1 protein during development. We also show that inhibiting the production of the QN1 protein during development leads to severe abnormalities in retina histogenesis, suggesting abnormal mitosis and differentiation.
Results

Kinetics of QN1 mRNA expression in chick neuroretina
The QN1 cDNA clone was isolated from a subtracted cDNA library. This library was constructed from a quail neuroretina cell clone immortalized by a thermosensible mutant of Rous sarcoma virus, which multiplied at 378C and became quiescent at 418C. We ®rst investigated the expression of QN1 mRNA during development by reverse transcription polymerase chain reaction (RT-PCR) ( Fig. 1) (we checked the speci®city of the PCR product by hybridization and sequencing). The QN1 gene was strongly expressed in the early stages (E5); the signal then decreased until E10 corresponding to the peak of the apoptotic wave during the development of the retina, increasing again thereafter. After hatching, the signal was strong and remained stable.
Analysis of the QN1 protein sequence
The amino sequence deduced from the nuclear sequence shows any domain or motif corresponding to a physiological function. We searched for a motif in the QN1 sequence that would predict subcellular distribution, using the PSORT II software (Fig. 2) . No N-terminal signal peptide was identi®ed, but we did ®nd two typical nuclear targeting sites (shown in red). The ®rst is monopartite and begins at aa 441 (PLHKKKS), and the second is a bipartite signal and begins at aa 484 (KKSIMKCRSPADKARSK). The protein contains 15.3% basic residues. Based on these results, the prediction of QN1 protein localization is nuclear (PSORT II). We identi®ed two potential PEST sequences (shown in green) (with the PEST search utility server). We identi®ed seven coiled-coil domains between aa 559 and 1242 with the multi-coil server (in blue).
Western blot of the QN1 protein
Western blots were performed with chick neuroretina at various stages of development (Fig. 3) . A clear signal was detected at 180 kDa (Fig. 3B) . The signal seems to be a doublet, with the relative intensities of the two bands varying during the course of development. On E8, the upper band predominated. At this stage, the signal was strong and the intensity of this band decreased until E16. On E12, we clearly detected a second band with a lower molecular mass (at this stage retina was completely post-mitotic since BrdU was negative as described) (see Fig. 7A ), the intensity of which increased with development until 12 days post-hatching (P12). The reaction was speci®c as no signal was obtained with pre-immune serum (Fig. 3A) , or if the immune serum was ®rst incubated with the recombinant QN1 protein (Fig. 3C) .
We studied the subcellular distribution of the QN1 protein by cellular fractionation and Western blotting with the nuclear and cytosolic extracts. We found that QN1 was present in the cytoplasm and nucleus at early stages of development. The QN1 in the cytoplasm corresponded to the upper band, whereas an intermediate form of QN1 was present in the nucleus, corresponding to QN1 expression in ganglion cells that are already post-mitotic. After hatching, QN1 was restricted to the nucleus and we detected only the lower band. Total RNA was extracted from neuroretinas at various stages (E5 3 P12) of development and the levels of QN1 and GAPDH mRNAs were determined by RT-PCR as described in Section 4. Densitometric analysis of QN1 mRNA levels corrected for GAPDH mRNA levels is shown below. The experiment shown is one of three independent trials, all of which gave similar results. E, embryonic day; P, post-hatching day. Fig. 2 . Predicted structure of QN1. We searched for known domains in the QN1 sequence. We found two potentials PEST sequences (in green), the two nuclear targeting sites are indicated in red and the coiled-coil domains are indicated in blue.
Cellular and subcellular localization of QN1
We studied the localization of QN1 protein during the development by immunochemistry and confocal microscopy with eye sections (Fig. 4) . At early stages (E5), when the tissue was not differentiated all the cells seemed to be labelled and the staining was limited to the cytoplasm. The signal observed on E8 was similar but slightly less intense. On E10 strong nuclear labelling was observed in ganglion cells (white arrow) and in some cells of the inner part of the inner nuclear layer (INL) corresponding to the amacrine cells. Some cells in the outer nuclear layer (ONL) were also labelled. On E12 and E16, the pattern was similar but with a larger number of positive cells. After hatching, all the layers were labelled and the signal was strongest in the nucleus of the ganglion cell layer (GCL) and the inner part of the INL. A signal was also detected in the nucleus and the inner segment of the photoreceptors but not in the Mu Èller cells.
We investigated the subcellular distribution of QN1 during development by confocal microscopy with isolated neuroretina cells (Fig. 5) . We used trypsin to dissociate neuroretina from eyes at various stages of development. The cells were ®xed with paraformaldehyde and immediately used for indirect immunohistochemical staining. In parallel, we quanti®ed the number of QN1-positive cells by¯uorescence-activated cell sorting. On E8, most (83.8%) of the cells were labelled. At this stage the labelling was cytoplasmic in most of these cells ( Fig. 5B ) but a few cells displayed nuclear labelling. On E15, the number of cells staining for QN1 was slightly higher (98.8%) and nuclear translocation of the protein had occurred, the cells now having strongly stained nuclei ( Fig.  5C ). At a higher magni®cation (Fig. 5D ) the signal was observed to be very intense and concentrated in the centre of the nucleus (white arrows). On P12 the pattern was similar to that on E15, with cytoplasmic labelling in some cells and strong nuclear labelling in other cells (Fig. 5E,F ), but the proportion of cells with nuclear labelling was higher than that on E15. We also carried out immunohistochemical staining of retina primary cell culture (data not shown). We Fig. 3 . Western blot analysis. (A) Immunoreactivity was analyzed in the retina at various stages of development. The immune anti-QN1 serum gave a signal at 180 kDa (b), compared to the control treated with pre-immune serum (a). The signal was a doublet. The upper band was the most intense on E8, but its intensity decreased with development and was no longer detected on E16. The lower band showed the opposite pattern, with the signal ®rst weakly detected on E10 clearly detected on E12 and increasing until P10. When the immune serum was ®rst incubated with the recombinant QN1 protein (as described in Section 4), the signal at 180 kDa disappeared speci®cally (c). (d) Control proteins loading of the different samples was checked with a-tubulin immunoreactivity. (B) Western blot analysis with fractionated cells. Controls were loaded on either side of the blot (total extract). On e6, the protein corresponding to the upper band was present in the cytoplasm (CE, cytosol extract), with an intermediate protein in the nucleus. After hatching, only the lower band was detected, and qn1 was restricted exclusively to the nucleus (NE, nuclear extract). Fig. 4 . QN1 localization during chick retina development. QN1 protein was studied by indirect immunohistochemistry with 10 mm eye sections observed by confocal microscopy. The QN1 labelling was revealed by Alexa 488 (in green) secondary antibody and the nuclei were dyed in red by propidium iodide. On E5 all the cells seemed to be labelled, and on E8 the pattern was similar but the signal was slightly less intense. On E10 the GCL, the inner part of the INL and the amacrine cells were strongly labelled. At high magni®cation, it was clear that this labelling was nuclear (white arrow). During development, the labelling spread in the retina, and on P12 all the cells were labelled. We observed intense nuclear labelling in the GCL and amacrine cells. The photoreceptors were also labelled and the plexiform layers were weakly labelled. PI, pre-immune serum; NE, neuroepithelium; IPL, inner plexiform layer; OPL, outer plexiform layer; RPE, retinal pigmented epithelium.
observed a clear signal in small refringent cells with long processes, indicative of neuronal morphology. The nuclei of these cells were labelled. In contrast, a very weak, exclusively cytoplasmic signal was detected in the¯at cells, which are thought to be Mu Èller cells. The labelling of QN1 in neurons corresponded to an area of the nucleus that was not stained or only lightly stained with 4
H ,6-diamindino-2-phenylindole (DAPI). We therefore investigated whether QN1 was associated with the nucleolus. We performed triple staining for QN1/®brillarin/DAPI (Fig. 6) . The results clearly show that QN1 (white arrow) did not co-localize with the nucleolus, which was labelled with ®brillarin (arrowhead).
2.5. Role of QN1 in the control of cell proliferation using a retroviral strategy
We investigated whether QN1 was involved in the control of cell proliferation using a retroviral antisense strategy to repress QN1 protein expression. We inserted a 1372 bp fragment of the QN1 cDNA, including the ATG initiation codon, into an RCAS vector. We produced virus RCAS alone as a control or a virus containing the cDNA in antisense. These viruses were used to infect neuroretina explant culture or injected in the eyes at E2.5.
In vitro experiments
The explant culture was performed at E6 and infected immediately with the viruses RCAS and RCAS QN1-AS. We checked the ef®ciency of viral infection after 1 day in vitro by testing the presence of the virus by immunochemistry using an antibody directed against the protein p27 gag of the capsid. The same p27 signal was detected in cells infected with either RCAS or antisense construct (Fig. 7Ba,b) . We performed immunochemistry with anti-QN1 serum to verify the QN1 expression in these cultures. QN1 was signi®cantly decreased in cells infected with the antisense construct compared to the RCAS control (Fig. 7Bc,d) .
We incubated the explant culture with BrdU overnight. In vitro after 1 day we observed 50% of BrdU-positive cells, and the same proportion of BrdU-positive cells in vivo at E7 (Fig.  7A ) (with the same time of incubation of BrdU). In vivo the cells stop to divide between E10 and E12. In vitro the cells exit from the cell cycle after 5 days, which corresponds to E11. The explant culture allows mimicking very well in vitro of the withdrawal of the cell cycle observed in vivo. In this condition we observed 66.1^0.7% of BrdU-positive cells in the explants infected with the antisense construct versus 49.9^1.05% for the control after 1 day in vitro. This represent 30% more S phases in the antisense condition than the control (Fig. 7C) . Thus, the QN1 downregulation prevents cells from cell cycle withdrawal transiently, since its decrease allow us to estimate a signi®cant extended number of additional S phase cells only beyond the normal period of the retina proliferation that occurs during histogenesis.
In vivo experiments
These viruses were injected into the vitreous humour of the eyes of chick embryos at 2.5 days of development to Fig. 5 . confocal microscopy study of QN1 protein expression with isolated retina cells. (A) Pre-immune serum. On E8 (B) some of the cells were labelled. This labelling was mostly cytoplasmic but a few cells showed weak nuclear labelling. On E15 (C) we observed two kinds of labelling. Some cells displayed cytoplasmic labelling, whereas others showed intense nuclear staining (white arrows). (D) A confocal microscopy image of cells on E15, but at higher magni®cation. This image is a superimposition of immuno¯uorescence staining, showing the nucleus in red (propidium iodide), QN1 in green (Alexa 488) and phase contrast to show the cell. The signal is very intense and concentrated in the centre of the nucleus (white arrows). On P12 (E,F) the labelling pattern was similar but with a higher proportion of cells with nuclear labelling. Fig. 6 . Co-localization of QN1 and ®brillarin. This image is a superimposition of immuno¯uorescence, showing QN1 in green (Alexa 488), ®brillarin in red (Texas Red) and the nucleus in blue (DAPI). QN1 (white arrow) is present in the DAPI-negative area of the neuron nucleus but is not associated with the nucleolus (arrowhead). Scale bar, 10 mm.
investigate the effect of a lack of QN1 protein in ovo. The embryos were killed at various stages, the eyes were mounted and sections were frozen cut. We investigated the following:
² The morphology of the retina by histological staining with haemalun eosin (Fig. 8A,B ,E,F,I,J,M,N). ² The spreading of the virus by immunohistochemistry with an antibody against a protein of the capsid (p27 gag) (Fig. 8C,G,K,O) . ² The production of QN1 protein by immunohistochemistry (Fig. 8D ,H,L,P).
We ®rst analyzed histology of the retinas 10 days after injection, and we observed severe abnormalities (Fig.  8E,F,I ,J,M,N) in retinas of the eye injected with the RCAS QN1-AS virus compared to the controls (Fig.  8A,B) . When we performed the immunochemistry studies we observed a total tissue infection (Fig. 8C ,G,K,O) and the anti-QN1 serum showed a strong decrease of QN1 protein expression (Fig. 8H ,L,P) compared to the control (Fig. 8D) .
The abnormalities appeared from E11 and involved abnormal thickening of the INL (Fig. 8E,F,I ,J,M,N), suggesting additional mitosis in the tissue, retinal infolding (Fig. 8E,F) , and rosette formation (Fig. 8I,M) . They resulted in a loss of the normal architecture of the tissue. These abnormalities, classically described in retinal dysplasia, persisted after hatching (data not shown). Thus, a lack of QN1 protein resulted in abnormal development of the retina, with structural modi®cations. These results demonstrate that the loss of QN1 protein leads to the deregulation of the cell proliferation that induces abnormal differentiation.
Discussion
In this study, we investigated the role of the QN1 protein during chick retina development. QN1 was isolated from an autosubtracted cDNA library as a gene involved in the control of neuroretina cell proliferation arrest. We have previously demonstrated (Bidou et al., 1993 ) the production of QN1 and BrdU incorporation in quail neuroretina cells in vivo, and have shown that the proportion of QN1-producing cells is inversely proportional to the number of BrdUlabelled cells. We used a polyclonal antibody to study QN1 protein levels during retina development.
In Western blot analysis, the QN1 signal was a doublet, with the relative intensities of the two bands varying during the course of development. The intensity of the upper band was high in early stages, whereas the lower band was detected only in post-mitotic stages. The difference in size of the two bands in the doublet may result from dephosphorylation or post-translational modi®cation, with cleavage of a small part of the protein. We then performed phosphorylation and dephosphorylation experiments with various kinases and phosphatases (data not shown). In these condi- The in vivo BrdU analysis shows that at early stages, until E5, most of the cells in the neuroepithelium are multiplying. During development, some cells become quiescent, differentiate and migrate to the lumen. The ®rst cells to stop dividing and to differentiate are the ganglion cells (E8), followed by the cells in the INL (E10). From E12 onwards, all the retinal cells have withdrawn from the cell cycle. ne, neuroepithelium; gcl, ganglion cell layer; ipl, inner plexiform layer; rpe, retinal pigmented epithelium; opl, outer plexiform layer; onl, outer nuclear layer. scale bar, 100 mm. To study the role of QN1 we performed an in vitro experiment. The neuroretina explants were dissected at E6 and infected with RCAS QN1-AS or RCAS alone as a control and cultured for several days. The explants were incubated with BrdU overnight before dissociation and seeding for counting S phase and monitoring the viral infection and the expression of the QN1 protein. In vivo at E7 50% of the cells were in the S phase and all the cells stopped dividing between E10 and E12. In vitro we obtained 50% of BrdU-positive cells after 1 day of culture and the cells stopped dividing after 5 days of culture, which corresponds to E11 (C). We show that our culture conditions mimic well the in vivo cell cycle withdrawal of the neuroretina. (B) (a,b) Immunochemistry against the p27 gag to check the viral infection. (c,d) Immunochemistry to verify the expression of QN1 immunochemistry. The lower pictures are the nuclear staining with the DAPI of the same ®elds. Explants culture infected with (a,c) the control virus (mock RCAS) and (b,d) the antisense retrovirus (RCAS QN1-AS). scale bar, 50 mm. (C) We found that the neuroretina infected with the RCAS QN1-AS shows 30% more of the S phase than the control until 4 days in vitro. The data are expressed as the mean^SD of duplicate cultures from a representative experiment. We performed a Student's t-test and the P value was extremely signi®cant (P , 0:0002).
tions, we observed changes in the pro®le of QN1 protein mobility in sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The changes in the QN1 pro®le due to phosphorylation or dephosphorylation suggest that these post-translational modi®cations are probably responsible for the difference in QN1 protein size during the development. Translocation of QN1 protein into the nucleus coincided with the change in the size of the protein. Thus, the phosphorylation state of the protein seems to be important for nuclear translocation. It is possible that phosphorylation or dephosphorylation exposes a nuclear targeting sequence present in QN1.
We investigated whether QN1 was localized into the nucleolus by immunochemistry or with a particular nuclear structure by electron microscopy with QN1 antibody. QN1 is clearly not associated with the nucleolus; it seemed to be present in the nucleoplasm compartment and not associated with a particular nuclear structure.
Cell cycle analysis and QN1 production experiments in suspensions of neuroretina cells at various stages of the development showed that the translocation of QN1 to the nucleus coincided with establishment of the quiescent state.
To assess the role of QN1 protein in cell cycle withdrawal we have inhibited the QN1 expression in neuroretina explant cultures by a retroviral antisense strategy. In these conditions we clearly observed additional cell divisions during the normal period of the retina proliferation. We could not expand the time of the multiplication in this tissue (we did not ®nd S phase after 5 days in vitro in our culture conditions). A different explanation could be given. First, the strong decrease of QN1 protein expression could compensate the programmed cell death for the extra cell division seen in retina cells infected with the antisense RCAS construct. Second, certainly the most probable explanation is the existence of compensatory mechanisms (Dyer and Cepko, 2000; Levine et al., 2000) which will lead to (A,B) . Much lower levels of QN1 labelling were observed in retinas injected with the antisense retrovirus. In this retina, major histological abnormalities are observed. The lamellar structure is highly perturbed and the INL is extensively thickened and irregular. We also observed infolding and/or rosette formation in these retinas. gcl, ganglion cell layer; ipl, inner plexiform layer; inl, inner nuclear layer; opl, outer plexiform layer; onl, outer nuclear layer; rpe, retinal pigmented epithelium. Scale bars, 500 mm (A,E,I,M), and 100 mm for all other pictures. extended cell divisions before differentiation. The arrest of cell proliferation is certainly due to a combination of several cell cycle inhibitors and the inhibition of only one of these factors is not suf®cient to permit the long-term proliferation.
On the other hand, in vivo experiments using the same retroviral antisense strategy resulted in numerous retinal abnormalities with large abnormal thickness of the INL, retinal infolding and rosette formation. These abnormalities clearly suggest a deregulation of the retina proliferation program that induces abnormal differentiation. Levine et al. (2000) showed that the p27Kip1 plays a key role in the cell cycle exit in neuroretina, and also plays a role in the abnormal differentiation of the Mu Èller cells which induces retinal dysplasia. In a similar manner, Dyer and Cepko (2000) showed that p57Kip2 also plays a role in the differentiation of the amacrine interneurons.
During the development, the exit of the cell cycle and the differentiation are closely linked. Different studies indicated that molecules involved in the regulation of the cell cycle are also involved in the retina differentiation. Thus, like CDKI, QN1 could be implicated in both withdrawal of the cell cycle and differentiation of neuroretina, as suggested by the observation of BrdU incorporation in vitro and retinal dysplasia in vivo.
Experimental procedures
RNA preparation and RT-PCR
Total RNA was extracted from chick neuroretina by guanidium isothiocyanate treatment and acid phenol extraction. The RNA was treated with RNase-free Dnase I to eliminate any trace of DNA, and was extracted with phenol. Total RNA (1 mg) was reverse transcribed by incubation with 200 units of Moloney murine leukemia virus (GIBCO BRL) and random hexamers (Pharmacia Biotech) in 1£ PCR buffer, 4 mM MgCl 2 , 5 mM DTT, 20 units of RNase out (GIBCO BRL), and 0.5 mM of each dNTP for 60 min at 428C. The resulting cDNA (2 ml) was added to the PCR mixture (1£ PCR buffer, 1.5 mM MgCl 2 , 0.2 mM of each dNTP, 2 ng/ml primer and 1.25 units of Taq polymerase (Perkin Elmer)). The ampli®cation was performed as follows: 948C for 2 min, followed by 22 cycles for glyceraldehyde phosphate dehydrogenase (GAPDH) (control) and 30 cycles for QN1 of 948C for 30 s, 548C for 30 s, 728C for 45 s, and then 728C for 2 min. The ampli®ed fragments were separated by electrophoresis in a 1% agarose gel and transferred onto Hybond N1 nylon membrane (Amersham). The speci®city of ampli®cation was checked by hybridization of the blots with an internal 32 P-labelled probe. The QN1 probe was obtained by Pst1 digestion of the QN1 cDNA clone. The resulting fragments were separated by electrophoresis in a 1% agarose gel and the band at 240 bp was excised and extracted from the gel using a Qiaquick kit (Qiagen SA). This cDNA fragment (50 ng) was labelled with [a 32 P]dCTP and the Multiprime labelling kit (Amersham). Unincorporated [a 32 P]dCTP was removed with a G50 column. An internal oligonucleotide labelled with [g 32 P]dCTP was used as a speci®c probe for GAPDH. Hybridization was performed overnight at 658C for QN1 and 428C for GAPDH. The blots were washed once in 1£ SSC, 0.1% SDS at 658C or 428C for 20 min and three times in 0.1£ SSC, 0.1% SDS at 658C or 428C for 20 min and placed against X-ray ®lms.
The intensity of bands was quanti®ed using a high-resolution camera coupled with an image processor (Ultra-lum, Inc.). NIH Image 1.62 software was used for densitometry. Results are expressed in arbitrary units as the ratio of QN1/ GAPDH levels.
The nucleotide sequences of the speci®c oligonucleotide primers used for PCR were as follows: QN1 sense (5
The nucleotide sequence of the probe used for hybridization was 5
H -GCTGA-CAATCTTGAGGGAGTTGTCATATTT-3 H .
Recombinant QN1 and antibody production 4.2.1. Production and puri®cation of the recombinant QN1
A plasmid containing 2736 bp of QN1 cDNA was ampli®ed by PCR using the following primers: sense (5 H -CGGGGTACCGAAGAAGGAAGCCTCACT-3 H ), and antisense (5 H -ACGCGTCGACATCTGCTGCTCTGTCTCT-3 H ) and PFU polymerase (Stratagen). The primers were designed to add a Kpn1 restriction site at the 5 H end of the sense primer and a Sal1 restriction site at the 3 H end of the antisense primer. The ampli®ed DNA fragment (bp) was inserted into the pCR II TOPO vector with the TOPO TA cloning kit (Invitrogen). The insert was removed by Kpn1/Sal1 digested and inserted into the PQE-30 expression vector (Qiagen), the resulting plasmid producing a recombinant protein with a regulators of Gprotein signalling 6xHis tag at the N-terminus. The construct was sequenced to check that no mutations were present. The resulting plasmid was used to transform E. coli strain M15pREP4. Isopropyl-1-thio-b-galactopyranoside-induced bacteria were lysed in 6 M guanidium chloride, and the recombinant protein was puri®ed on a Ni-NTA column (Qiagen) by elution with 8 M urea and a decreasing pH gradient. The puri®ed protein was renatured by four successive dialyses against 20 mM Tris containing 4, 2, 1 and 0 M urea, respectively. The protein was concentrated by ®ltration on a 50 kDa ultra free ®lter (Millipore) with phosphate-buffered saline (PBS).
Antibody production
We inserted a 2736 bp fragment into the 5 H region of the open reading frame in the E. coli expression vector PQE-30. The resulting plasmid encoded the QN1 protein fused to a 6xHis tag at the N-terminus. The histidine tag made it possi-ble to purify the recombinant protein on a nickel af®nity chromatography column. This protein, which had a molecular weight of 100 kDa, was used to immunize a rabbit. We then used immune serum from this rabbit in studies on the synthesis of the QN1 protein.
New Zealand white rabbits were immunized ®ve times with 200 mg of protein and complete Freund's adjuvant to obtain antiserum against QN1.
Western blot analysis
The neuroretina was dissected from chicks at various stages of development and homogenized in H buffer (10 mM Tris±HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% NP40, 1% Triton X-100) supplemented with protease inhibitor cocktail (Boehringer Mannheim). For the production of nuclear extract, neuroretinas were homogenized on ice in hypotonic lysis buffer I (10 mM Tris±HCl (pH 8.0), 0.1 mM EDTA, 2 mM magnesium acetate, 3 mM CaCl 2 , 1 mM DTT, 0.1% Triton X-100, 0.32 M sucrose) containing protease inhibitor cocktail with a Dounce homogenizer. Part of this homogenate was centrifuged at 100 000 £ g for 1 h at 48C and the supernatant, corresponding to the cytosol, was harvested. The rest of the homogenate was mixed with 1.5 vol. of buffer II (2 M sucrose, 5 mM magnesium acetate, 0.1 mM EDTA, 10 mM Tris±HCl (pH 8), 1 mM DTT), placed on a buffer II cushion and centrifuged at 30 000 £ g for 45 min at 48C. The pellet was washed once, and then harvested in H buffer.
Immunoblots were analyzed by one-dimensional 7.5% SDS-PAGE. The amount of protein was quanti®ed by BCA assay (Pierce) for every sample. Protein (20 mg per lane) was transferred to Immobilon membrane (Millipore), and incubated in antiserum, saturated serum or pre-immune serum diluted 1:8000 in PBS, 0.1% Tween-20, and 1% skimmed milk powder. The signal was detected with goat anti-rabbit immunoglobulin (Vector) conjugated to horseradish peroxidase, diluted 1:17 500 and detected by chemoluminescence (ECL1) (Amersham) according to the manufacturer's protocols.
To saturate the immune serum, 1 mg of recombinant protein was incubated with 1 ml of immune serum in 500 ml of 1% skimmed milk powder in 0.1% Tween in PBS for 45 min at room temperature on an orbital shaker. This mixture was diluted to obtain a dilution of 1:8000 of the immune serum before incubation with the membrane.
Histology and immunohistochemistry
Eyes sections
Eyes at various stages of development were dissected and ®xed overnight in 4% paraformaldehyde in PBS, washed in PBS and immersed in 20% sucrose in PBS. The eyes were mounted in Tissue tek OCT (Miles), frozen and stored at 2808C. Serial sections (10 mm) orthogonal to the pecten were cut with a Bright OTF/AS cryostat (D.I.S.), collected on gelatin-coated slides and stored at 2208C.
Cell culture
Primary cultures were set up as previously described (Crisanti-Combes et al., 1978) . The cells were washed three times in PBS and ®xed by incubation for 20 min in 4% paraformaldehyde in PBS, and then washed thoroughly in PBS.
For retinal explant the retinas were dissected away from surrounding tissue in Hanks' balanced salt solution without Ca 21 and Mg
21
. The retinas from several embryos were transferred in culture medium (1 vol. DMEM (GIBCO)/1 vol. F12 nutrient mix (GIBCO)/1 mM HEPES/1% calf foetal serum/0.1% chicken foetal serum) and cut in pieces of 1 mm 2 . Five explants of retinas were placed on polycarbonate ®lter nucleopore (Nalgen) which were previously equilibrated with 1.5 ml of medium. The explants were infected with the antisense QN1 RCAS construction (RCAS QN1-AS) or the RCAS alone as a control at the time of dissection. Medium (20 ml) was added daily to the explants.
BrdU labelling
To label the cells, which were in the S phase in the explants, we added 20 mM of BrdU in explant medium for the night. After incubation, to perform the immunodetection of BrdU, the explants were washed, dissociated and 0.5 £ 10 5 cells were then plated for 2 h on poly-d-lysine (Sigma)-coated, eight-well glass slides (Polylabo). For each condition two wells were plated. The cells were washed with PBS, ®xed for 10 min in 4% paraformaldehyde, washed twice in PBS, and stored in methanol at 2208C. BrdU was detected as previously described (Bidou et al., 1993) . For each well the percentage of cells in the S phase was determined as the average of the percentage of cells in the S phase of a minimum of ®ve ®elds which represented a minimum of 2000 cells. For each ®eld the percentage of S phase was determined as follows: %S phase (number of BrdU-positive cells/number of cells DAPI-labelled). Each condition was performed in duplicate.
For in vivo labelling, BrdU (50 mg) was administered dropwise through a window in the eggshell onto several embryos at each stage. The shells were sealed with adhesive tape and the eggs were returned to the incubator for the night. The eyes of the embryo were ®xed in 4% paraformaldehyde and mounted for cryosectioning, as described above.
Immunohistochemistry
Cells or eye sections were washed in PBS, and permeabilized in blocking solution (5% skimmed milk powder, 0.1% Triton X-100 in PBS) for 45 min. Both primary and secondary antibodies were diluted in 1% skimmed milk powder and 0.1% Triton X-100 in PBS. For gag immunohistochemistry, the anti-p27 immunoglobulin (Life Technologies) was diluted 1:1000 and incubated with the cells or sections for 1 h. After rinsing in 1% skimmed milk in PBS, biotinylated secondary antibody (Amersham) was added and the incubation was continued for 1 h. The cells or sections were then rinsed in PBS, and this was followed by ampli®cation with extravidin-FITC (Sigma) at 1:100 for 1 h. For QN1 labelling, the anti-QN1 serum was diluted 1:500 and incubated with the cells or sections for 1 h; the secondary antibody was a goat anti-rabbit immunoglobulin conjugated to Alexa 488 (Molecular Probes) and diluted 1:250.
For ®brillarin, we used the GM4 antibody (Fomproix et al., 1998) diluted 1:100 and the secondary antibody was an anti-human immunoglobulin coupled to Texas Red and diluted 1:50. The DNA-speci®c dye DAPI (4 mg/ml) was added 5 min before the end of the incubation.
Confocal microscopy
Confocal microscopy was performed with eye sections and suspensions of neuroretina cells. For eye sections, the protocol was as described above. For cell suspensions, the cells were incubated with 0.25% trypsin in PBS for 30 min at 378C, washed three times in PBS and ®xed by incubation for 20 min in 4% paraformaldehyde in PBS. The cells were washed three times in PBS and then incubated in 10% bovine serum albumin, and 0.1% Triton X-100 in PBS (blocking reagent). The cells were incubated with immune serum diluted 1:500 in blocking reagent for 30 min, washed again and incubated with the secondary antibody (anti-rabbit immunoglobulin conjugated to Alexa 488 1:250). The cells were washed three times. During the last wash, the cells were treated for 5 min with the nuclear stain, propidium iodide (0.4 mg/ml in PBS). The cells were mounted in Mowiol (Sigma) and observed by confocal microscopy.
Confocal microscopy and scanning were carried out using an ACAS 570 Interactive laser cytometer (Meridian Instruments, Inc., Okemos, MI) equipped with confocal optics. The system consisted of a 5 W argon ion laser, an Olympus IMT-2 microscope with a 100£ oil immersion objective, Zaxis control, an XY scanning stage, and a variable spindle aperture under 80486 computer control.
Construction and growth of RCAS QN1
4.5.1. Retrovirus construction RCAS, which was described by Petropoulos and Hughes (1991) , has a unique ClaI cloning site. We cloned a fragment of the QN1 cDNA that included the initiator codon ATG. A clone of QN1 was digested with Pst1 to generate a 1372 bp fragment (2132, 11240), which was inserted into the polylinker of the adaptor vector Cla12 (Hughes et al., 1987) to generate ClaI extremities. The insert was removed by ClaI digestion and inserted into RCAS. We obtained several clones, which were sequenced to determine their orientation. We selected one clone in the antisense orientation (RCAS QN1-AS).
Virus production
The recombinant RCAS was then used to transfect chick embryo ®broblasts (White Leghorn HAAS) (0.2 £ 10 6 cells/ cm 2 in a 25 cm 2¯a sk) by overnight calcium phosphate precipitation followed by two washes with PBS (Chen and Okayama, 1987) . When the cells reached con¯uence, they were transferred to a 150 cm 2¯a sk (1:12). Some of the cells were ®xed to check for the presence of the virus by immunohistochemistry with an antibody against a protein of the capsid (p27 gag, Life Science). When the cells were almost con¯uent, the medium was removed and replaced with a minimal volume of fresh medium. The supernatant was harvested every day, ®ltered on 0.45 mm pore (Nalgen) ®lters to remove cellular debris and ultracentrifuged at 100 000 £ g for 2 h. The pellet was resuspended in a minimum volume of culture medium, and aliquots were frozen at 2808C.
Retrovirus injection into the eye
White Leghorn eggs were incubated until E2.5 in humidi®ed rocking incubator at 388C. Then they were transferred to a static incubator 1 h before opening the shell. A 1 cm 2 window was made with small scissors on the upper side of the eggshell to expose the embryo. At this stage, injections were made with a Wild M420 binocular macroscope (Leica) with a borosilicate micropipette (Phymep, 1 mm external diameter and 0.58 mm internal diameter). The micropipette was attached to the micromanipulator (Leitz) and ®lled with the virus suspension. Approximately 1 or 2 ml were injected into one eye. To monitor the injection, a 1:10 vol. of tracking dye (0.25% Fast Green in PBS, ®lter sterilized) was added to the concentrated virus suspension. The virus solution ®lled the eye cup and then¯owed into the neural tube through the optic stalk, which is still continuous with the ventricular system of the brain at these stages. The window in the eggshell was sealed with adhesive tape, and the egg was returned to a non-rocking incubator at high humidity.
